Celanese Corporation (CE) has been the subject of numerous market reports, showing mixed assessments of its financial health and outlook. The company's average rating among brokerages is 'Hold'. Interestingly, the law firm of Pomerantz initiated an investigation on the firm due to claims made by investors. Following an inventory destocking disclosure, the firm's shares dropped by 13%. Lately, its performance has sparked attention, collapsing due to unidentified reasons. Nonetheless, it is set to present its Q3 performance for 2025 on November 7. Despite facing potential volatility, the corporation acquired substantial investments from Muhlenkamp & Co. Inc., HB Wealth Management, and others. Various analyst estimates on its Q2 earnings project revenue and EPS beyond expectancy. However, Weiss Rating reiterated the 'Sell' rating for the firm. Amid these evaluations and critical situations, strategic moves made in response to market challenges are something to look out for according to earnings call highlights. The corporation's valuation has been under scrutiny, buoyed by analyst upgrades and optimism about auto demand with its shares oscillating substantially. Jim Cramer emphasized that the rise of chemical prices and China stepping back online is critical for Celanese's recovery.
Celanese Corporation CE News Analytics from Wed, 04 Dec 2024 08:00:00 GMT to Sat, 11 Oct 2025 06:41:05 GMT -
Rating -3
- Innovation 2
- Information 3
- Rumor -2
